With the new technology we see, with new research, the evolvement of medicines. I believe the proposed new amendment will be too restrictive. This, the principal bill, needs to be allowed to be flexible so that we have expert regulators that can keep up with these evolving medicines, technology, and research. And I feel like this new proposal would restrict that.